Targeting Dopamine Receptors Subtype 2 (D2DR) in Pheochromocytomas: Head-to-Head Comparison Between In Vitro and In Vivo Findings

Alexandru Saveanu(Inserm), David Taïeb(Aix-Marseille Université), Cendrine Archange(Aix-Marseille Université), Fausto Palazzo(Hammersmith Hospital), F. Sébag(Hôpital de la Conception), Benjamin Guillet(Inserm), Wassim Essamet, Anne Barlier(Inserm)
The Journal of Clinical Endocrinology & Metabolism
September 6, 2013
Cited by 5


Related Papers